PRESS RELEASE
6 October 2026

Bankruptcy Judge Rejects Diocese Of Oakland's Chapter 11 Plan

LS
Lowenstein Sandler

Contributor

Lowenstein Sandler LLP is a national law firm with over 400 lawyers based in New York, Palo Alto, Roseland, Salt Lake City, San Francisco, Washington, D.C., and Wilmington. We represent clients in virtually every sector of the global economy, with particular strength in the areas of technology, life sciences, and investment funds.

A federal bankruptcy judge has delivered a landmark ruling rejecting the Diocese of Oakland's Chapter 11 reorganization plan, determining that religious institutions must meet the same stringent Bankruptcy Code requirements as secular entities. The court
United States

Bankruptcy Judge William J. Lafferty has rejected the Diocese of Oakland’s Chapter 11 plan, ruling that the Diocese failed to satisfy the Bankruptcy Code’s requirements for confirmation of a plan of reorganization.

Lowenstein Sandler’s Bankruptcy & Restructuring Department has served as counsel to the Official Committee of Unsecured Creditors, which is comprised of survivors of sexual abuse, in the Chapter 11 bankruptcy case of the Roman Catholic Bishop of Oakland (California) since its filing in May 2023.

In a decision of monumental importance for nonprofit religious institutions seeking bankruptcy protection, the Court found no basis to apply the Bankruptcy Code differently or more leniently because the Diocese is a religious entity. The court also held that the Debtor’s liquidation analysis was done in a way so as to tilt the playing field in the Catholic church's favor.

The Lowenstein team includes Jeffrey D. Prol, Brent Weisenberg, Michael A. Kaplan, Colleen M. Restel, and Nicole Fulree.

Contributor

Lowenstein Sandler LLP is a national law firm with over 400 lawyers based in New York, Palo Alto, Roseland, Salt Lake City, San Francisco, Washington, D.C., and Wilmington. We represent clients in virtually every sector of the global economy, with particular strength in the areas of technology, life sciences, and investment funds.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More